Haplotypes are now widely used in association studies between markers and disease susceptibility locus. However, when a large number of markers are considered, the number of possible haplotypes increases leading to two problems: an increased number of degrees of freedom that may result in a lack of power and the existence of rare haplotypes that may be difficult to take into account in the statistical analysis. In a recent paper, Durrant et al proposed a method, CLADHC, to group haplotypes based on distance matrices and showed that this could considerably increase the power of the association test as compared to either single-locus analysis or haplotype analysis without prior grouping. Although the authors considered different one-disease-locus susceptibility models in their simulations, they did not study the impact of the linkage disequilibrium (LD) pattern and of the susceptibility allele frequency on their conclusions. Here, we show, using haplotype data from five regions of the genome of different lengths and with different LD patterns, that, when a single disease susceptibility locus is simulated, the prior grouping of haplotypes based on the algorithm of Durrant et al does not increase the power of association testing except in very particular situations of LD patterns and allele frequencies.
Introduction
A large number of single nucleotide polymorphisms (SNPs) can now be used to look for an association between a disease and a candidate gene. These markers can either be studied one at a time or jointly in haplotypes. The advantages of haplotypic versus single-marker methods have been widely debated in the literature: some studies show that haplotypic tests are more powerful, 1 -3 whereas others conclude that single-site analysis should be preferred. 4 -6 However, the relative power of these two approaches depends on whether the disease contributing SNPs are among the investigated SNPs or not, 7, 8 on the number of disease susceptibility sites, 8 on the disease susceptibility model and on the type of interactions between disease contributing sites. 9, 10 The number of SNPs that are considered jointly in haplotypes is also an important parameter since the number of haplotypes increases with the number of investigated SNPs and, consequently, increase the degrees of freedom of tests comparing cases and controls, thus reducing their power. Moreover, as some haplotypes would only be carried by a few individuals, there could be statistical problems owing to small sample sizes making difficult the evaluation of their possible effect on the susceptibility. To face this problem, different strategies have been developed for the grouping of haplotypes. 
The three tests
The data were analyzed using the CLADHC software, 12 kindly provided by Caroline Durrant. This program considers overlapping sliding windows of SNPs across the haplotypes. In each window, three association tests are performed:
A single-locus allele-based analysis using Pearson's w For each window, the program also provides a significant threshold calculated using the Bonferroni correction. The single-locus test is corrected for the number of SNPs, T[h] is corrected for the number of windows and T[MAX] is corrected for the number of windows and for the number of levels in the tree.
The simulation process
We start by selecting a site as the disease susceptibility (DS) site in the studied gene. In the following, we will assume that the minor allele at this locus is the one that confers the highest risk of disease (DS allele). For IL13, PLAU, TNF, CHR20_1 and CHR20_2, all the SNPs are considered as the susceptibility site in turn, except when two sites are in complete LD. In this latter case, only one of the two sites is studied. For the CARD15 region, as the computation time is really longer due to the larger haplotypic diversity in the data set, only nine SNPs out of the 13 are analyzed.
Results
Results of the power computations are presented in Table 1 and in Figures 1 and 2 . In Table 1 , the power to detect an association is presented for site 13 of the CARD15 region. As expected, the power of the three tests is higher when the homozygote GRR is high, and when the susceptibility site is included in the analysis. The same results are obtained for all the sites on the four genes.
The power of the three tests for an homozygote GRR of 2 is presented in Figures 1 and 2 for different values of DS allele frequency and for different maximum linkage disequilibrium (LD max , based on the r 2 values) between the susceptibility site and another site. Whatever the test, we can see that the power increases when the DS allele frequency and the LD max increase. The difference in power for the three tests can be tested by a Friedman two-way analysis of variance. As our data sets are heterogeneous, we test separately the data sets corresponding to long sequences (CHR20_l, CHR20_2 and CARD15) and to short sequences (IL13, PLAU and TNF).
The two groups are referred to as LS and SS, respectively. When the susceptibility site is present (Figure 1 ), we find that the power of the three tests is statistically different at the 1% level for LS and SS. As expected in this case, the single-locus test is more powerful than the two others since the use of haplotypes increases the number of tests without adding any information. The difference in power between the two haplotypic tests is not significant at the 5% level for both LS and SS. When the susceptibility site is removed (Figure 2) , the difference in power between the three tests is significant at the 1% level for LS and at the 5% level for SS. The pairwise comparisons of the three tests show that T[h] and T [MAX] are not significantly different at the 5% level for both LS and SS and that the single-locus test is more powerful than the two other tests. The power of the singlelocus test is particularly high when LD max is high. However, it should be noted that for the haplotypic tests, the results in the overlapping windows are highly correlated. Thus, they may suffer a greater loss of power due to the Bonferroni correction than the single-locus test. With a less conservative correction for multiple testing, the difference of power between the single-locus test and the haplotypic tests should be reduced.
For an homozygote GRR of 5, the powers are very high for all the three tests (around 100% for 66% of the tested sites), and no significant difference is observed between the three tests.
In this study, as in Durrant et al, 12 we assume that haplotypes can be reconstructed without ambiguity. If this is not the case, haplotype uncertainty should be taken into account in the haplotypic tests and their power will be reduced. The power of the single-locus test will not be affected and thus the difference in power between the tests will be increased.
Discussion
The results obtained in this study turn out to be very different from those published by Durrant et al, 12 although the same software is used. For the same GRR values, our Bardel et al, 20 the various clustering or phylogeny-based methods might be more powerful when more than one susceptibility site are involved in the disease and be more efficient to precisely localize these susceptibility sites along the haplotypes. Further investigations should confirm these points.
